Advanthera S.L

Advanthera is a specialized partner dedicated to accelerating the development and clinical translation of Advanced Therapy Medicinal Products (ATMPs), including cell therapies, gene therapies and tissue-engineered products.

Our mission is to help innovative therapies reach patients faster, safely and in full regulatory compliance. Unlike traditional service providers, Advanthera combines two highly specialized business units under one integrated model: Regulatory Pathways, providing strategic regulatory consulting, CMC, Quality & GMP compliance, ATMP development, Clinical Trial Applications (CTA), Scientific Advice, Hospital Exemption, Quality Management Systems, technology transfer and regulatory support from early development through marketing authorization; and Precise Supply, delivering GMP-compliant clinical supply services, including Qualified Person (QP) certification, GMP storage, cold-chain logistics, comparator sourcing, packaging and labeling, import/export management and global distribution of investigational medicinal products.

By integrating regulatory expertise with operational execution, Advanthera becomes a single trusted partner capable of supporting biotech companies, pharmaceutical sponsors, hospitals and academic institutions throughout the entire development pathway, from concept to clinical trial and beyond.

Based in Spain and operating across Europe, our multidisciplinary team combines scientific, regulatory and operational expertise to solve the complex challenges associated with Advanced Therapies, ensuring agility, quality and compliance at every stage. Advanthera is your one-stop partner for transforming breakthrough science into clinical reality.